Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 14.96% is 20% below its 5-year average of 18.72%, near the low end of its 5-year range (12.50%–24.85%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.47% below its 12-month average of 15.66%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 14.96%.
RETURN ON INVESTED CAPITAL (ROIC)
14.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
15.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
18.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
18.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-4.47%
CURRENT VS 3Y AVG
-17.01%
CURRENT VS 5Y AVG
-20.12%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.07%
median of 785 covered companies
CURRENT VS SECTOR MEDIAN
+142.65%
vs the sector median at left
Harmony Biosciences Holdings, Inc.
Market Cap
$2.28B
Return on Invested Capital (ROIC)
14.96%
TTM Avg
15.66%
3Y Avg
18.02%
5Y Avg
18.72%
Market Cap
$2.27B
Return on Invested Capital (ROIC)
16.96%
TTM Avg
-12.78%
3Y Avg
-0.83%
5Y Avg
5.59%
Market Cap
$2.31B
Return on Invested Capital (ROIC)
-77.92%
TTM Avg
-42.31%
3Y Avg
-48.27%
5Y Avg
-40.00%
Market Cap
$2.33B
Return on Invested Capital (ROIC)
46.99%
TTM Avg
-39.61%
3Y Avg
-45.77%
5Y Avg
-48.25%
Market Cap
$2.35B
Return on Invested Capital (ROIC)
27.60%
TTM Avg
29.86%
3Y Avg
13.68%
5Y Avg
-0.60%
Market Cap
$2.37B
Return on Invested Capital (ROIC)
-49.78%
TTM Avg
-43.13%
3Y Avg
-47.40%
5Y Avg
-42.10%
Market Cap
$2.39B
Return on Invested Capital (ROIC)
-26.95%
TTM Avg
-26.95%
3Y Avg
-26.95%
5Y Avg
-26.95%
Market Cap
$2.40B
Return on Invested Capital (ROIC)
-4.62%
TTM Avg
-19.11%
3Y Avg
-45.14%
5Y Avg
-60.93%
Market Cap
$2.42B
Return on Invested Capital (ROIC)
-10.24%
TTM Avg
1.21%
3Y Avg
1.35%
5Y Avg
3.39%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | $2.28B | 14.96% | 15.66% | 18.02% | 18.72% |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.27B | 16.96% | -12.78% | -0.83% | 5.59% |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.31B | -77.92% | -42.31% | -48.27% | -40.00% |
| Liquidia Corporation (LQDA)vs › | $2.33B | 46.99% | -39.61% | -45.77% | -48.25% |
| ADMA Biologics, Inc. (ADMA)vs › | $2.35B | 27.60% | 29.86% | 13.68% | -0.60% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.37B | -49.78% | -43.13% | -47.40% | -42.10% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.39B | -26.95% | -26.95% | -26.95% | -26.95% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | -4.62% | -19.11% | -45.14% | -60.93% |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.42B | -10.24% | 1.21% | 1.35% | 3.39% |
| Disc Medicine, Inc. (IRON)vs › | $2.42B | -38.21% | -29.01% | -27.76% | -29.57% |
ROIC
15.0%
ROE
18.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 14.96% |
| 2026-03-31 | 12.50% |
| 2025-12-31 | 13.90% |
| 2025-09-30 | 18.09% |
| 2025-06-30 | 18.83% |
| 2025-03-31 | 16.82% |
| 2024-12-31 | 17.22% |
| 2024-09-30 | 15.68% |
| 2024-06-30 | 17.08% |
| 2024-03-31 | 21.14% |
| 2023-12-31 | 21.53% |
| 2023-09-30 | 24.85% |
| 2023-06-30 | 21.65% |
| 2023-03-31 | 20.91% |
| 2022-12-31 | 20.13% |
| 2022-09-30 | 18.81% |
| 2022-06-30 | 21.83% |
| 2022-03-31 | 22.38% |
| 2021-12-31 | 21.20% |
| 2021-09-30 | 17.67% |
| 2021-06-30 | 15.97% |
| 2021-03-31 | 13.16% |
| 2020-12-31 | 5.41% |
| 2020-09-30 | -8.88% |
| 2020-06-30 | -44.53% |
| 2020-03-31 | -62.99% |
| 2019-12-31 | -168.07% |
